Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

Download

Full text for this resource is not available from the Research Repository.

Export

Tacar, Oktay, Sriamornsak, Pornsak and Dass, Crispin R (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. Journal of Pharmacy and Pharmacology, 65 (2). pp. 157-170. ISSN 0022-3573 (print) 2042-7158 (online)

Abstract

The frontline drug doxorubicin has been used for treating cancer for over 30 years. While providing a cure in select cases, doxorubicin causes toxicity to most major organs, especially life-threate ning cardiotoxicity, which forces the treatment to become dose-limiting.

Dimensions Badge

Altmetric Badge

Item type	Article
URI	https://vuir.vu.edu.au/id/eprint/23703
DOI	10.1111/j.2042-7158.2012.01567.x
Official URL	http://onlinelibrary.wiley.com/doi/10.1111/j.2042-...
Subjects	Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences Historical > FOR Classification > 1112 Oncology and Carcinogenesis Historical > FOR Classification > 1115 Pharmacology and Pharmaceutical Sciences
Keywords	ResPubID26676, ResPubID25795, cancer, cardiotoxicity, chemotherapy, doxorubicin, drugs, pharmaceuticals
Citations in Scopus	1684 - View on Scopus
Download/View statistics	View download statistics for this item